biosite developed or perfected the first assay, cd4, for the pima. clondiag developed the hardware and software. like you said 1/08 on this board about the analyzer:
"Mitcheroo, Listen to the presentation at the JP Morgan conference. They will not be a competitor for Abbott. This company is into point of care tests. They will set their test up to monitor the progress or remission of cancer. This will be a big seller for them and management at IMA are well aware of what they have. The device they have under development will run both molecular and immunoassays."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.